David Moller

Company: Variant Bio

Job title: Chief Scientific Officer

Seminars:

Human Genetics Driven Drug Discovery for Cardio-Renal & Metabolic Disease 11:40 am

Exemplifying the value of human genetics for selection of therapeutic targets leading to increased clinical success rates Explaining Variant Bio’s differentiated approach and opportunities for partnerships Sharing examples of novel approaches (including kidney disease-focused) based on genetic supportRead more

day: Summit Day 2

Panel Discussion: Bypassing Injectables: Exploring Oral Innovations to Increase Patient Compliance 2:40 pm

How to maintain comparable efficacy and achieve oral bioavailability? What are manufacturing and supply chain nuances- how can these be addressed to ensure adequate and cost-efficient market supply?Read more

day: Summit Day 2